A brief overview of the emergency department (ED) based induction to buprenorphine program initiated at Yale New Haven Hospital. This report describes a randomized controlled trial that provided patients with opioid use disorder seen in the emergency room with either a substance use disorder screening and referral to treatment, a screening and brief intervention with facilitated referral to treatment, or induction to buprenorphine medicated assisted treatment and a referral to follow up treatment. Those patients offered buprenorphine were significantly more likely to be engaged in treatment 30 days later than the other patients. This model has subsequently been adopted in EDs across the country. This report is part of the Addiction Policy Forum’s Spotlight series which highlights innovative programs to address the opioid crisis.
Funding source: Various grants and donations
This resource was produced by an individual/organization receiving funding from sources that have a conflict of interest such as a pharmaceutical company, political action committee, or other industry-related sources. Multiple studies indicate that research performed by individuals with relationships to industry and research funded by industry sources are more likely to favor the sponsor’s products. Industry funding of charities and non-profit organizations has also been linked to groups supporting industry-favorable positions. For more information, please visit the CLOUD 101 page.
An overview of a program which offers patients seen in the emergency department with opioid use disorder with immediate access to mediation assisted treatment and referral to treatment.